Menu
POTENTIAL DEAL DETAILS
| Stock | Syneos Health, Inc. | Symbol | SYNH |
| Date Announced | 02/27/2023 | Source | Reuters |
| Type | News Report |
| Date of Confirmation: | 05/10/2023 | Price at Confirmation: | $41.85 |
| Potential Profit: | 0.43% | Annualized Profit: | 2.19% |
According to Reuters, Syneos Health Inc (SYNH), eyes sale of the company as contract backlog shrinks.
Update(s):
May 9, 2023: According to Bloomberg, A consortium that includes Elliott Investment Management, Patient Square Capital and Veritas Capital is in advanced talks to acquire Syneos Health (SYNH).
May 10, 2023: Syneos Health (SYNH) announced that it has entered into a definitive agreement to be acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management (“Elliott”), Patient Square Capital (“Patient Square”), and Veritas Capital (“Veritas”) for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt.
Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.